Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
CHE Chemed Corp
- Stocks
- Healthcare
- NYSE: CHE
Price (delayed)
$552.5
Market cap
$8.08B
P/E Ratio
26.68
Dividend/share
$2
EPS
$20.71
Enterprise value
$8.05B
Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of
Highlights
The EPS has increased by 10% YoY and by 3% from the previous quarter
The net income has grown by 9% year-on-year and by 2.2% since the previous quarter
Chemed's quick ratio has increased by 30% from the previous quarter but it has decreased by 9% YoY
The debt is up by 3% since the previous quarter
Key stats
What are the main financial stats of CHE
Market
Valuations
Earnings
Shares outstanding
14.63M
Market cap
$8.08B
Enterprise value
$8.05B
Price to earnings (P/E)
26.68
Price to book (P/B)
6.84
Price to sales (P/S)
3.25
EV/EBIT
19.53
EV/EBITDA
16.93
EV/Sales
3.24
Revenue
$2.49B
Gross profit
$866.66M
Operating income
$388.92M
Net income
$308.74M
EBIT
$412.34M
EBITDA
$475.6M
Free cash flow
$318.39M
Per share
Balance sheet
Liquidity
EPS
$20.71
EPS diluted
$20.52
Free cash flow per share
$21.77
Book value per share
$80.74
Revenue per share
$170.22
TBVPS
$66.31
Total assets
$1.73B
Total liabilities
$544.75M
Debt
$145.06M
Equity
$1.18B
Working capital
$211.83M
Debt to equity
0.12
Current ratio
1.73
Quick ratio
1.58
Net debt/EBITDA
-0.06
Margins
Efficiency
Dividend
EBITDA margin
19.1%
Gross margin
34.8%
Net margin
12.4%
Operating margin
15.6%
Return on assets
17.9%
Return on equity
26%
Return on invested capital
65.3%
Return on capital employed
28.7%
Return on sales
16.6%
Dividend yield
0.36%
DPS
$2
Payout ratio
9.7%
CHE stock price
How has the Chemed stock price performed over time
Intraday
-0.86%
1 week
1.18%
1 month
-3%
1 year
2.74%
YTD
4.28%
QTD
-10.21%
Financial performance
How have Chemed's revenue and profit performed over time
Revenue
$2.49B
Gross profit
$866.66M
Operating income
$388.92M
Net income
$308.74M
Gross margin
34.8%
Net margin
12.4%
Chemed's operating income has increased by 14% YoY and by 6% from the previous quarter
The net income has grown by 9% year-on-year and by 2.2% since the previous quarter
The revenue rose by 9% year-on-year and by 2.4% since the previous quarter
CHE's gross profit is up by 7% year-on-year
Price vs fundamentals
How does CHE's price correlate with its fundamentals
Growth
What is Chemed's growth rate over time
Valuation
What is Chemed stock price valuation
P/E
26.68
P/B
6.84
P/S
3.25
EV/EBIT
19.53
EV/EBITDA
16.93
EV/Sales
3.24
The EPS has increased by 10% YoY and by 3% from the previous quarter
The price to earnings (P/E) is 7% lower than the 5-year quarterly average of 28.8 and 4.9% lower than the last 4 quarters average of 28.3
The P/B is 22% less than the 5-year quarterly average of 8.9 and 4.2% less than the last 4 quarters average of 7.2
Chemed's equity has increased by 6% from the previous quarter
CHE's P/S is 9% below its 5-year quarterly average of 3.6 and 7% below its last 4 quarters average of 3.5
The revenue rose by 9% year-on-year and by 2.4% since the previous quarter
Efficiency
How efficient is Chemed business performance
The company's return on invested capital fell by 6% YoY
The ROS has increased by 4.4% YoY
The ROE has contracted by 2.3% YoY
The ROA rose by 2.3% since the previous quarter and by 2.3% year-on-year
Dividends
What is CHE's dividend history
DPS
$2
Dividend yield
0.36%
Payout ratio
9.7%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Chemed financials performed over time
Chemed's quick ratio has increased by 30% from the previous quarter but it has decreased by 9% YoY
CHE's current ratio is up by 25% from the previous quarter but it is down by 9% YoY
The debt is 88% smaller than the equity
CHE's debt to equity is down by 8% since the previous quarter
Chemed's equity has increased by 6% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.